Name
Merus N.V.
Company Description
At Merus, we are clinically advancing leading-edge, targeted treatments to address the unmet needs of patients with various types of cancer. Utilizing our proprietary technology platforms, we are developing innovative multispecific antibody therapeutics, referred to as Multiclonics®.
Website
Product Categories (7)
Gastrointestinal (Colorectal) Cancer, Head and Neck Cancer, Biotechnology, Clinical Research, Clinical Trials
Featured Exhibitor
Yes
Address
Cambridge, MA
United States
United States
Products
Relevance
Clinical Trials
Merus Pipeline
Badges
